Skip to main navigation Skip to search Skip to main content

NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS

  • Jeffrey Wefel
  • , Stephanie Pugh
  • , Ali Choucair
  • , Barbara Fisher
  • , Sherry Fox
  • , Christina Meyers
  • , Lynn Ashby
  • , Tom Mikkelsen
  • , Jon Glass
  • , Michael Yu
  • , Steven Howard
  • , Benjamin Movsas
  • , Minesh Mehta

Research output: Contribution to conference › Presentation

Original languageAmerican English
DOIs
StatePublished - Nov 11 2019
EventNeuro-oncology -
Duration: Nov 11 2019 → …

Conference

ConferenceNeuro-oncology
Period11/11/19 → …

Disciplines

  • Oncology
  • Internal Medicine
  • Medicine and Health Sciences
  • Immunology and Infectious Disease

Cite this